host picture

Why CHEO is launching a lawsuit about gene patents

This morning, CHEO launched a legal challenge against American patent holders of genes related to a rare heart disorder called Long QT Syndrome. The problem is that testing for this disorder must be done in the U.S., for a high cost, or CHEO risks being sued by the holders of the patent for the related gene being tested. This issue has come up in the States, where the U.S. Supreme Court ruled patents cannot be placed on genes. And now CHEO wants a similar decision in Canada. CEO Alex Munter joined us to explain.


Download Flash Player to view this content.

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Submission Policy

Note: The CBC does not necessarily endorse any of the views posted. By submitting your comments, you acknowledge that CBC has the right to reproduce, broadcast and publicize those comments or any part thereof in any manner whatsoever. Please note that comments are moderated and published according to our submission guidelines.